» Articles » PMID: 16205785

Effects of Cholinesterase Inhibiting Sage (Salvia Officinalis) on Mood, Anxiety and Performance on a Psychological Stressor Battery

Overview
Date 2005 Oct 6
PMID 16205785
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Salvia officinalis (sage) has previously been shown both to possess in vitro cholinesterase inhibiting properties, and to enhance mnemonic performance and improve mood in healthy young participants. In this double-blind, placebo-controlled, crossover study, 30 healthy participants attended the laboratory on three separate days, 7 days apart, receiving a different treatment in counterbalanced order on each occasion (placebo, 300, 600 mg dried sage leaf). On each day mood was assessed predose and at 1 and 4 h postdose. Each mood assessment comprised completion of Bond-Lader mood scales and the State Trait Anxiety Inventory (STAI) before and after 20 min performance of the Defined Intensity Stress Simulator (DISS) computerized multitasking battery. In a concomitant investigation, an extract of the sage leaf exhibited dose-dependent, in vitro inhibition of acetylcholinesterase and, to a greater extent, butyrylcholinesterase. Both doses of sage led to improved ratings of mood in the absence of the stressor (that is, in pre-DISS mood scores) postdose, with the lower dose reducing anxiety and the higher dose increasing 'alertness', 'calmness' and 'contentedness' on the Bond-Lader mood scales. The reduced anxiety effect following the lower dose was, however, abolished by performing the DISS, with the same dose also being associated with a reduction of alertness during performance. Task performance on the DISS battery was improved for the higher dose at both postdose sessions, but reduced for the lower dose at the later testing session. The results confirm previous observations of the cholinesterase inhibiting properties of S. officinalis, and improved mood and cognitive performance following the administration of single doses to healthy young participants.

Citing Articles

Plant extracts as emerging modulators of neuroinflammation and immune receptors in Alzheimer's pathogenesis.

Mohamed I, Osman E, Saeed A, Ming L, Goh K, Razi P Heliyon. 2024; 10(16):e35943.

PMID: 39229544 PMC: 11369442. DOI: 10.1016/j.heliyon.2024.e35943.


Antioxidant and Anti-Inflammatory Profiles of Two Mexican Species and Their Relevance for the Treatment of Mental Diseases: (L.) DC. and A. Juss. (Malpighiaceae).

Nieto Camacho A, Baca Ibarra I, Huerta-Reyes M Molecules. 2024; 29(13.

PMID: 38999004 PMC: 11243223. DOI: 10.3390/molecules29133053.


Neuroprotective Effect of Extract in Scopolamine-Induced Cognitive Impairment in Rats: Behavioral and Biochemical Approaches.

Lazarova M, Stefanova M, Denev P, Taseva T, Vassileva V, Tasheva K Biology (Basel). 2024; 13(6).

PMID: 38927306 PMC: 11201232. DOI: 10.3390/biology13060426.


Touch, feel, heal. The use of hospital green spaces and landscape as sensory-therapeutic gardens: a case study in a university clinic.

Dinu Roman Szabo M, Dumitras A, Mircea D, Doroftei D, Sestras P, Boscaiu M Front Psychol. 2023; 14:1201030.

PMID: 38078228 PMC: 10705765. DOI: 10.3389/fpsyg.2023.1201030.


Therapeutics to Treat Psychiatric and Neurological Disorders: A Promising Perspective from Algerian Traditional Medicine.

Larit F, Leon F Plants (Basel). 2023; 12(22).

PMID: 38005756 PMC: 10674704. DOI: 10.3390/plants12223860.